CLINICAL_TRIALS
trial_result
· 2016-02-15
Clinical Trial Update: Study of TG-C in Patients With Grade 3 Degenerative Joint Disease of the Knee [Phase 2]
Summary
Phase 2 study of TG-C for grade 3 degenerative joint disease of the knee (osteoarthritis) completed; results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kolon TissueGene, Inc. | Conditions: Osteoarthritis, Knee | Phase 2 | Status: COMPLETED | Results posted: 2016-02-15